Fertility Preservation Clinical Trial
Official title:
Correlation of Oxidative Stress and Oocyte Quality in Fertility Preservation
Whether it is for oncology or personal reasons, fertility preservation allows participants to preserve their oocytes (eggs) at their current age and condition for a better chance of having a baby in the future. In order to proceed with fertility preservation, participants will need to undergo in vitro fertilization (IVF), which is standard practice, and take stimulation medication to stimulate production of more follicles. The combination of both Rekovelle and Menopur for fertility preservation may increase ovarian response to stimulation and increase the number of oocytes retrieved to give better chances of embryos once the oocytes will be fertilized. The goal in this study is to understand the effect of oxydative stress on the quality of oocytes. For the purpose of the study and to evaluate this connection, serum levels of oxidative stress and cf-DNA in your blood will be measured. Oocyte quality will also be assessed with Magenta, a prediction tool utilizing artificial intelligence (AI). This method is non-invasive and has no risks on the oocytes.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Recruiting |
NCT06074796 -
The Determinants of Fertility Preservation in TRANSgender Patients.
|
||
| Completed |
NCT01448460 -
Oocyte Vitrification for In Vitro Fertilization (IVF) Patients and Women With Fertility Threatening Conditions
|
N/A | |
| Recruiting |
NCT02400827 -
Contamination of Ovarian Tissue by RT-PCR in Participants With Solid Tumors
|
N/A | |
| Recruiting |
NCT02400970 -
Contamination of Testicle Tissue by RT-PCR in Participants With Solid Tumors
|
N/A | |
| Recruiting |
NCT02895165 -
PREgnancy and FERtility Registry
|
||
| Not yet recruiting |
NCT03725280 -
Micro RNA Profile in the Ovarian Follicle Fluid of Transgender Men
|
||
| Recruiting |
NCT04904263 -
Advisory Board on Cancer, Infertility and Pregnancy
|
||
| Not yet recruiting |
NCT06289062 -
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT06289751 -
Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
|
Phase 2 | |
| Completed |
NCT01696786 -
Oocyte Cryopreservation
|
N/A | |
| Not yet recruiting |
NCT06468215 -
Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer
|
N/A | |
| Completed |
NCT01645241 -
Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation
|
N/A | |
| Completed |
NCT01160315 -
Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT06175832 -
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
|
Phase 4 | |
| Active, not recruiting |
NCT00827476 -
Improving Human Ovarian Transplantation
|
Phase 0 | |
| Completed |
NCT00380406 -
PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial
|
Phase 3 | |
| Active, not recruiting |
NCT03817814 -
Decisions of Young Women With Breast Cancer Regarding Fertility Preservation Before Cancer Treatment and Family Building After Treatment
|
||
| Recruiting |
NCT05443737 -
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
|
Phase 3 | |
| Completed |
NCT05100498 -
Web-based Oncofertility Support Tool for Reproductive-age Women With Breast Cancer
|
N/A |